Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms — Stella

Recruiting

Back to Neuroendocrine (NE) Tumors trials

Trial locations(1 site)

Sweden

Akademiska Sjukhuset, Uppsala

Key details

Sponsor

Uppsala University

Enrollment target

~94 participants

Started

March 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov